Other OTC - Delayed Quote • USD
Northwest Biotherapeutics, Inc. (NWBO)
At close: April 26 at 3:59 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BOSCH MARNIX L Chief Technology Officer | Stock Award(Grant) | Apr 3, 2023 | 119,355 |
| BOYNTON ALTON L Officer and Director | Stock Gift | Sep 19, 2011 | 2,894,090 |
| CAUDILL RANDALL L W Director | Purchase | Mar 13, 2003 | 10,700 |
| COGNATE BIOSERVICES, INC. Beneficial Owner of more than 10% of a Class of Security | Sale | Jun 30, 2015 | 18,460,400 |
| JASINOWSKI JERRY J Director | Stock Award(Grant) | Feb 3, 2020 | 1,891,350 |
| MALIK NAVID Director | Sale | Nov 17, 2023 | -- |
| NORTHWEST HOSPITAL Beneficial Owner of more than 10% of a Class of Security | Sale | Dec 16, 2003 | 1,891,940 |
| POWERS LINDA F Chief Executive Officer | Sale | Dec 28, 2018 | -- |
| TOUCAN CAPITAL FUND II L P Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Jun 22, 2007 | -- |
| WILDS DANIEL O Chief Executive Officer | Purchase | Apr 3, 2003 | 72,500 |
Related Tickers
CVM CEL-SCI Corporation
1.4400
-0.69%
AVXL Anavex Life Sciences Corp.
3.4400
+1.47%
TLSA Tiziana Life Sciences Ltd
0.7801
-8.22%
ANVS Annovis Bio, Inc.
18.01
+32.43%
ANIX Anixa Biosciences, Inc.
3.2300
+8.39%
ATNM Actinium Pharmaceuticals, Inc.
6.87
+4.73%
CTXR Citius Pharmaceuticals, Inc.
0.6648
-9.25%
NRXP NRx Pharmaceuticals, Inc.
3.5400
+12.74%
CYDY CytoDyn Inc.
0.1430
-2.05%
OTLK Outlook Therapeutics, Inc.
8.43
+2.93%